James Mackay is the founder of Aristea Therapeutics. Aristea Therapeutics has raised $205M in total funding. Latest round: Series A. Based in San Diego, CA.
James Mackay, Ph.D., is the co-founder and CEO of Crystalys Therapeutics, a San Diego-based biotech company focused on developing treatments for gout. The company successfully raised $205 million in a Series A financing round. Mackay previously led the development and approval of Zurampic (lesinurad) and co-founded Aristea Therapeutics. Crystalys Therapeutics was launched in 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library